Virtual Meeting to be held with CEO Valliant on April 21 hosted by Truist.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on FUSN:
- Fusion Pharmaceuticals’ FPI-2059 shows tumor growth inhibition
- Fusion Pharmaceuticals management to meet virtually with Truist
- Fusion Pharmaceuticals receives IND clearance for Alpha therapy FPI-2068
- Fusion Pharmaceuticals: First patient dosed in Phase 1 Study of FPI-2059
- Fusion Pharmaceuticals Announces Fourth Quarter 2022 Financial Results and Clinical Program Updates